Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma

Yuki Shirane(Hiroshima University), Shiro Oka(Hiroshima University)
Cancers
March 28, 2024
Cited by 4


Related Papers